Select a community
All Communities
Home > Community Treatment Reports > Trankimazin (alprazolam) Treatment Report
What is Trankimazin?

This is an international trade name for alprazolam, a benzodiazepine used in the treatment of anxiety disorder (GAD); panic disorder, with or without agoraphobia; anxiety associated with depression.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Anxiety 1 0
Insomnia 1 0

Mouse over the table for more information

Dosages

  0.25 mg daily 1 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.